Novus has a first-mover advantage in obtaining a lion-share of the market through its established branding initiatives and consumer loyalty before other competitors even began to move into the cannabis sector.

Unlike conventional insurance carriers, the Novus program offers significant cost-savings on legal cannabis meds and other supplemental health plans. Conflicting federal and state laws surrounding this burgeoning industry has caused widespread confusion, leading to conventional insurance companies continuing to refuse coverage of hemp, cannabidiol (CBD), medical cannabis (THC) and alternative/ integrative treatment options for patients.

The Novus model is unique, by focusing on the deficiencies of private and government health plans in the US and Canada by integrating supplemental plans that include legal cannabis meds for recreational and medicinal users.

The main reasons behind Novus’ head start in this health insurance sector can be attributed to three factors: 

  Since cannabis is not legal federally, many major insurance carriers will not jeopardize their multi-billion-dollar Federal Medicare/Medicaid contracts by doing business in this sector.

  Insurance companies generally don’t favor meds that have not been approved by the US Food & Drug Administration (FDA).

  Major carriers usually concentrate on acquiring market share as opposed to creating it.